Cargando…
PO-1249 The impact of COVID-19 pandemic in the lung cancer treatment in a radiotherapy service
Autores principales: | Costa, S., Pires, A.M., Figueiredo, T., Cardia, J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Ireland Ltd.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9153898/ http://dx.doi.org/10.1016/S0167-8140(22)03213-3 |
Ejemplares similares
-
PO-1198 Changes in radical radiotherapy for lung cancer patients in the UK during the COVID-19 pandemic.
por: croxford, W., et al.
Publicado: (2021) -
PO-1165 Dosimetric parameters in hypofractionated radiotherapy in NSCLC cohort during SARS-COV-2 pandemia
por: González Ruiz, M.A., et al.
Publicado: (2021) -
PO-1174 3-weekly paclitaxel-carboplatin with radiation for stage III NSCLC – option during COVID-19 pandemic
por: Wong, H., et al.
Publicado: (2021) -
PO-1179 Radiation induced pneumonitis during COVID-19: artificial intelligence for differential diagnosis.
por: Ippolito, E., et al.
Publicado: (2021) -
PO-1181 Hypofractionation in NSCLC as the new standard of care during SARS-CoV-2 pandemia.
por: Vera Barragán, V., et al.
Publicado: (2021)